NORGES BANK - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 112 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$2,023,000
+110.7%
577,900
+36.7%
0.00%
Q4 2014$960,000
+16.9%
422,8150.0%0.00%
Q3 2014$821,000
-73.3%
422,815
-50.0%
0.00%
-100.0%
Q2 2014$3,070,000
+15.1%
845,630
+22.9%
0.00%
-50.0%
Q1 2014$2,668,000
+36.1%
687,8150.0%0.00%
+100.0%
Q4 2013$1,960,000
-20.4%
687,8150.0%0.00%0.0%
Q3 2013$2,462,000
+7.2%
687,8150.0%0.00%0.0%
Q2 2013$2,297,000
-16.9%
687,815
+69.0%
0.00%
-50.0%
Q1 2013$2,763,000
-33.8%
406,9160.0%0.00%
-33.3%
Q3 2012$4,171,000
+7.4%
406,916
+14.7%
0.00%0.0%
Q2 2012$3,882,000354,8870.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Tamarack Advisers, LP 8,350,000$28,557,0005.86%
Ion Asset Management Ltd. 3,632,132$12,422,0001.43%
CM Management, LLC 500,000$1,710,0001.27%
SECTOR GAMMA AS 1,530,490$5,234,0000.96%
Rhenman & Partners Asset Management AB 1,520,000$5,198,0000.36%
Rock Springs Capital Management LP 4,742,000$16,218,0000.35%
Telemetry Investments, L.L.C. 90,000$308,0000.35%
DAFNA Capital Management LLC 275,500$942,0000.22%
KELLEHER FINANCIAL ADVISORS 100,000$342,0000.22%
Virtus ETF Advisers LLC 91,971$315,0000.13%
View complete list of RIGEL PHARMACEUTICALS INC shareholders